Results of recombinant growth hormone treatment in children with end-stage renal disease on regular hemodialysis
Children with chronic kidney disease are at high risk for growth retardation and decreased adult height. Growth hormone (GH) treatment is known to stimulate growth in children with short stature suffering from chronic kidney disease. However, the extent to which this the-rapy affects final adult hei...
Main Author: | Doaa Mohammed Youssef |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=4;spage=755;epage=764;aulast=Youssef |
Similar Items
-
Galectin-3 as an early marker of diastolic dysfunction in children with end-stage renal disease on regular hemodialysis
by: Akram Elsadek, et al.
Published: (2022-01-01) -
Mucocutaneous Changes in End-Stage Renal Disease Under Regular Hemodialysis - A Cross-Sectional Study
by: Asmaa A Ras, et al.
Published: (2023-01-01) -
Dyslipidemia among Patients with End Stage Renal Disease on Maintenance Hemodialysis
by: Mohammed Ghazi Abdulhadi, et al.
Published: (2018-07-01) -
Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis
by: Laura Cotoi, et al.
Published: (2020-04-01) -
Cutaneous Manifestations in Patients with End Stage Renal Disease on Hemodialysis
by: Azar Shirzadian Kebria, et al.
Published: (2023-09-01)